
Respiratory District Sales Manager, Ontario GTA East – 1 year contract
City : 7333 Mississauga Road North
Category : Other
Industry : Healthcare
Employer : GSK
Site Name: Canada - Ontario - Mississauga
Posted Date: Mar 6 2023
Posted Date: Mar 6 2023
Details (Your responsibilities)
- Delivers GTA East District Business Performance
- Translates performance drivers, company, brand objectives, and strategies to develop a winning business plan for the Montreal East Respiratory business.
- Models and effectively coaches to a competitive mindset
- Sets and clearly communicates expectations and priorities; monitors and reports progress, and adjusts team plans, priorities, or direction as needed
- Allocates resources to highest value / highest return opportunities
- Unlocks levers and business accelerators; helps others “connect the dots” across the business
- Engages directly and supportively with select key customers and other partners to add value
- Encourages innovation and risk-taking; builds a “balanced portfolio” of opportunities sufficient to over-deliver on targets
- Facilitates and leads the GTA East Respiratory Sales Team
- Drives performance through coaching excellence and building a winning, inclusive team environment
- Supports the growth of each direct report by accurately diagnosing capability strengths & gaps and providing targeted on-going formal and informal coaching appropriate to their specific needs, goals, strengths, opportunities, and style
- Uses situational leadership and a variety of approaches & styles when coaching, facilitating and leading
- Actively builds and promotes diversity in teams
- Creates the supportive environment for highly motivated teams and engaged, empowered, highly motivated business owners
- Models Business ownership attitudes and behaviours and exhibits and fosters GSK’s desired culture
- Leads and models GSK Values to all team members
- Advocates and coach teams to be ambitious for patients, accountable for impact, and do the right thing
- Keep current on relevant matters including company business policy, and procedures to insure 100% compliant implementation.
- Manage and control expenses to maximize return on investment.
Why you?
Basic Qualifications
- Minimum of a bachelor’s degree
- Minimum of 2+ years’ experience has a sales representative
- Minimum 2 years Marketing / Product Management with tactical planning and implementation experience in the pharmaceutical industry
- Proven strength in strategic thinking and analytics
- Demonstrated proficiency with omnichannel to optimize customer experience
- Excellent strategic business ownership skills
- Ability to translate knowledge of selling skills and strategy to upskill Sales Representatives across a range of skills sets and experience
- Experience in building strong cross functional partnerships
- Valid driver's license
- Ability to travel domestically as necessary
- Candidate must be able to travel extensively in the Quebec province.
Required Qualifications
- Respiratory expertise, and strong understanding of the Ontario respiratory market is an asset
- Excellent understanding of the changing healthcare environment
- Winning listening and communication skills through all media
- High emotional intelligence and agility
- Comfortable challenging status quo, working in ambiguity, ability to take initiative, manage multiple priorities and work in a fast-paced environment.
This position requires the employee to drive routinely on Company business and allows for the provision of a company – leased vehicle. However, to be eligible for this position and a company vehicle, GSK will need to obtain acceptable results from a license verification inquiry and drivers abstract review against its safe driver program requirements.
Why GSK?
Uniting science, technology and talent to get ahead of disease together
We’re uniting science, technology and talent to make a difference in more people’s lives, and revolutionising the way we do R&D.
We’re combining the power of genetic and genomic insights into what causes disease, with the speed and scale of artificial intelligence and machine learning (AI/ML) to make better predictions about who a treatment might work for, and why. We believe this powerful combination of data and technology holds the key to fundamentally transforming medical discovery for the better, improving R&D success rates and shaping how even the most challenging diseases, like neurological conditions and cancer, can be both prevented and treated.
No single scientist, nor any one technology can keep us all ahead of disease. That’s why we build important collaborations with commercial and academic partners to advance our understanding of disease and what it takes to get ahead. In the past three years, we’ve doubled the number of partnerships we’ve signed, because of our belief in their significant impact on our process.
Our pipeline currently comprises of more than 60 vaccines and medicines across four core therapeutic areas including infectious diseases, HIV, oncology and immunology as well at pursuing other science-led opportunities outside our core areas. Many have the potential to be first or best-in-class opportunities for patients and since 2017, we’ve delivered 13 major approvals and more than doubled the number of potential new vaccines and medicines in Phase 3 and registration to 23.
In 2021 we delivered four major product approvals: Cabenuva for HIV, Jemperli for endometrial cancer, Xevudy for COVID-19 and Apretude, our new long-acting medicine for HIV prevention.
We give our scientists the freedom to own the process. Our scientists often use genetic data to help us understand the root cause of disease. We steer the research where the data shows we can do the most good. If a project doesn’t pan out, we take what we’ve learned and apply it elsewhere.
Find out more:
#LI-GSK
By 2031, we aim to deliver more than £33 billion in annual sales – a step-change in performance and growth which will significantly increase the positive impact we can have on the health of billions of patients around the world. And we’re confident in our future.
Since 2017, we’ve delivered 13 major approvals and more than doubled the number of potential new vaccines and medicines in Phase 3 and registration to 23. Our pipeline of 21 vaccines and 43 medicines includes many with potential to be first or best-in-class opportunities for patients.
In 2021 we delivered four major product approvals: Cabenuva for HIV, Jemperli for endometrial cancer, Xevudy for COVID-19 and Apretude, our new long-acting medicine for HIV prevention.
GSK’s portfolio spans three product areas: vaccines, specialty and general medicines and our focus is to deliver better and faster for patients globally. We’re prioritising investment in vaccines and specialty medicines, which we expect to grow to around three quarters of our business in the next five years.
Our unrivalled vaccine portfolio targets infectious diseases at every stage of life, helping to reduce the burden of disease for hundreds of millions of people. GSK has exceptional capabilities in vaccine science and technologies, including adjuvant/protein and mRNA.
In specialty medicines, we are at the forefront of HIV prevention and treatment, and we are building our presence in key therapeutic areas such as oncology and immuno-inflammation.
General medicines include our inhaled medicines for asthma and COPD, antibiotics and medicines for skin diseases.
Every day, GSK medicines and vaccines protect and improve health, making life better for millions of people all over the world.
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years.
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy. We’re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.
GSK is an equal opportunity employer committed to diversity and inclusion. We welcome applications from all qualified individuals to apply to our career opportunities. GSK is committed to accommodating persons with disabilities. If you need accommodation at any stage of the application process or want more information on our accommodation policies, please contact us at canada-recruitment@gsk.com. Please do not send resumes to this e-mail and instead apply through the online application process of this posting.
As a health and science-based organization, GSK is committed to following the recommendations as set out by Health Canada and taking all necessary steps to help curb the spread of COVID-19 which includes getting the COVID-19 vaccine. We feel strongly that this is the best way to help protect those we value most: our employees, families, communities and the patients and consumers we serve. To that end, we are taking an important step to ensure the safety of our employees during this global public health crisis.
Only employees who are fully vaccinated against COVID-19 may attend our Mississauga and Laval corporate offices. In addition, all customer-facing employees who, as part of their job, attend healthcare settings such as hospitals, pharmacies, doctors’ offices and dentists’ offices will need to be fully vaccinated against COVID-19. Notwithstanding the foregoing, employees may seek an accommodation for human rights-related reasons, including medical or disability-related conditions, or religious beliefs.
Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.